358 related articles for article (PubMed ID: 25144514)
1. Tea component, epigallocatechin gallate, potentiates anticataleptic and locomotor-sensitizing effects of caffeine in mice.
Kasture SB; Gaikar M; Kasture V; Arote S; Salve B; Rosas M; Cotti E; Acquas E
Behav Pharmacol; 2015 Feb; 26(1-2):125-32. PubMed ID: 25144514
[TBL] [Abstract][Full Text] [Related]
2. Caffeine and muscarinic antagonists act in synergy to inhibit haloperidol-induced catalepsy.
Moo-Puc RE; Góngora-Alfaro JL; Alvarez-Cervera FJ; Pineda JC; Arankowsky-Sandoval G; Heredia-López F
Neuropharmacology; 2003 Sep; 45(4):493-503. PubMed ID: 12907310
[TBL] [Abstract][Full Text] [Related]
3. Caffeine withdrawal retains anticataleptic activity but Withania somnifera withdrawal potentiates haloperidol-induced catalepsy in mice.
Kasture S; Barhate S; Mohan M; Ballero M; Sanna C; Maxia A
Nat Prod Res; 2009; 23(8):724-8. PubMed ID: 19418355
[TBL] [Abstract][Full Text] [Related]
4. The potency and efficacy of anticholinergics to inhibit haloperidol-induced catalepsy in rats correlates with their rank order of affinities for the muscarinic receptor subtypes.
Erosa-Rivero HB; Bata-García JL; Alvarez-Cervera FJ; Heredia-López FJ; Góngora-Alfaro JL
Neuropharmacology; 2014 Jun; 81():176-87. PubMed ID: 24534110
[TBL] [Abstract][Full Text] [Related]
5. Increases in blood pressure and heart rate induced by caffeine are inhibited by (-)-epigallocatechin-3-O-gallate: involvement of catecholamines.
Han JY; Kim CS; Lim KH; Kim JH; Kim S; Yun YP; Hong JT; Oh KW
J Cardiovasc Pharmacol; 2011 Oct; 58(4):446-9. PubMed ID: 21975870
[TBL] [Abstract][Full Text] [Related]
6. Effects of co-administration of tea epigallocatechin-3-gallate (EGCG) and caffeine on absorption and metabolism of EGCG in humans.
Nakagawa K; Nakayama K; Nakamura M; Sookwong P; Tsuduki T; Niino H; Kimura F; Miyazawa T
Biosci Biotechnol Biochem; 2009 Sep; 73(9):2014-7. PubMed ID: 19734672
[TBL] [Abstract][Full Text] [Related]
7. Effects of the psychoactive compounds in green tea on risky decision-making.
Liley AE; Joyner HN; Gabriel DBK; Simon NW
Behav Pharmacol; 2022 Feb; 33(1):32-41. PubMed ID: 35007234
[TBL] [Abstract][Full Text] [Related]
8. Antagonism of haloperidol-induced swim impairment in L-dopa and caffeine treated mice: a pre-clinical model to study Parkinson's disease.
Luthra PM; Barodia SK; Raghubir R
J Neurosci Methods; 2009 Apr; 178(2):284-90. PubMed ID: 19146880
[TBL] [Abstract][Full Text] [Related]
9. Low dosage of rasagiline and epigallocatechin gallate synergistically restored the nigrostriatal axis in MPTP-induced parkinsonism.
Reznichenko L; Kalfon L; Amit T; Youdim MB; Mandel SA
Neurodegener Dis; 2010; 7(4):219-31. PubMed ID: 20197647
[TBL] [Abstract][Full Text] [Related]
10. The local application of a flavonoid, (-)-epicatechin, increases the spiking of globus pallidus neurons in a dose-dependent manner and diminishes the catalepsy induced by haloperidol.
Alatorre A; Oviedo-Chávez A; Villalobos N; Ríos A; Barrientos R; Querejeta E
Behav Pharmacol; 2015 Feb; 26(1-2):117-24. PubMed ID: 25503260
[TBL] [Abstract][Full Text] [Related]
11. Coadministration of epigallocatechin-3-gallate (EGCG) and caffeine in low dose ameliorates obesity and nonalcoholic fatty liver disease in obese rats.
Yang Z; Zhu MZ; Zhang YB; Wen BB; An HM; Ou XC; Xiong YF; Lin HY; Liu ZH; Huang JA
Phytother Res; 2019 Apr; 33(4):1019-1026. PubMed ID: 30746789
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic potential of alpha2 adrenoceptor antagonism for antipsychotic-induced extrapyramidal motor disorders.
Imaki J; Mae Y; Shimizu S; Ohno Y
Neurosci Lett; 2009 Apr; 454(2):143-7. PubMed ID: 19429072
[TBL] [Abstract][Full Text] [Related]
13. Functional interaction between adenosine A2A and group III metabotropic glutamate receptors to reduce parkinsonian symptoms in rats.
Lopez S; Turle-Lorenzo N; Johnston TH; Brotchie JM; Schann S; Neuville P; Amalric M
Neuropharmacology; 2008 Sep; 55(4):483-90. PubMed ID: 18625257
[TBL] [Abstract][Full Text] [Related]
14. Involvement of adenosinergic receptor system in an animal model of tardive dyskinesia and associated behavioural, biochemical and neurochemical changes.
Bishnoi M; Chopra K; Kulkarni SK
Eur J Pharmacol; 2006 Dec; 552(1-3):55-66. PubMed ID: 17064683
[TBL] [Abstract][Full Text] [Related]
15. Protective effect of green tea polyphenol (-)-epigallocatechin gallate and other antioxidants on lipid peroxidation in gerbil brain homogenates.
Lee SR; Im KJ; Suh SI; Jung JG
Phytother Res; 2003 Mar; 17(3):206-9. PubMed ID: 12672147
[TBL] [Abstract][Full Text] [Related]
16. The effects of adenosine A2A receptor antagonists on haloperidol-induced movement disorders in primates.
Varty GB; Hodgson RA; Pond AJ; Grzelak ME; Parker EM; Hunter JC
Psychopharmacology (Berl); 2008 Oct; 200(3):393-401. PubMed ID: 18594798
[TBL] [Abstract][Full Text] [Related]
17. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo.
Thangapazham RL; Singh AK; Sharma A; Warren J; Gaddipati JP; Maheshwari RK
Cancer Lett; 2007 Jan; 245(1-2):232-41. PubMed ID: 16519995
[TBL] [Abstract][Full Text] [Related]
18. (-)-Epigallocatechin-3-gallate blocks the induction of nitric oxide synthase by down-regulating lipopolysaccharide-induced activity of transcription factor nuclear factor-kappaB.
Lin YL; Lin JK
Mol Pharmacol; 1997 Sep; 52(3):465-72. PubMed ID: 9281609
[TBL] [Abstract][Full Text] [Related]
19. Effects of tandospirone, a 5-HT1A agonistic anxiolytic agent, on haloperidol-induced catalepsy and forebrain Fos expression in mice.
Ohno Y; Shimizu S; Imaki J
J Pharmacol Sci; 2009 Apr; 109(4):593-9. PubMed ID: 19352073
[TBL] [Abstract][Full Text] [Related]
20. In vitro cytotoxicity of epigallocatechin gallate and tea extracts to cancerous and normal cells from the human oral cavity.
Weisburg JH; Weissman DB; Sedaghat T; Babich H
Basic Clin Pharmacol Toxicol; 2004 Oct; 95(4):191-200. PubMed ID: 15504155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
